$MBC Balance Sheet | Understand Stock

$MBC

$6.91 +$0.23 (3.44%) Close

$MBC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 28, 2026	Q1 FY2026 As of Mar 29, 2026	Q4 FY2025 As of Dec 28, 2025	Q3 FY2025 As of Sep 28, 2025	Q2 FY2025 As of Jun 29, 2025	Q1 FY2025 As of Mar 30, 2025	Q4 FY2024 As of Dec 29, 2024	Q3 FY2024 As of Sep 29, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 24, 2023	Q2 FY2023 As of Jun 25, 2023	Q1 FY2023 As of Mar 26, 2023
ASSETS
Current assets
Cash and cash equivalents
Accounts receivable, net
Inventories
Other current assets
TOTAL CURRENT ASSETS
Property, plant and equipment, net of accumulated depreciation
Operating lease right-of-use assets, net of accumulated amortization
Goodwill
Other intangible assets, net of accumulated amortization
Other assets
TOTAL ASSETS
LIABILITIES AND EQUITY
Current liabilities
Accounts payable
Current portion of long-term debt
Current operating lease liabilities
Other current liabilities
TOTAL CURRENT LIABILITIES
Long-term debt
Deferred income taxes
Other postretirement plan liabilities
Operating lease liabilities
Other non-current liabilities
TOTAL LIABILITIES
Equity
Common stock (par value $0.01 per share; authorized 750.0 million shares; 128.8 million shares issued and 128.1 million shares outstanding as of June 25, 2023; 128.0 million shares issued and outstanding as of December 25, 2022)
Common stock (par value $0.01 per share; authorized 750.0 million shares; 209.4 million issued and 203.4 million outstanding as of June 28, 2026; 132.6 million issued and 127.2 million outstanding as of December 28, 2025)
Paid-in capital
Treasury stock, at cost
Accumulated other comprehensive (loss) income
Retained earnings
TOTAL EQUITY

TOTAL LIABILITIES AND EQUITY
Common stock outstanding (in shares)

Comments